000			01970 a2200517 4500
005			20250515224715.0
264		0	_c20101004
008			201010s 0 0 eng d
022			_a1872-7980
024	7		_a10.1016/j.canlet.2010.04.026 _2doi
040			_aNLM _beng _cNLM
100	1		_aPapi, Alessio
245	0	0	_aRXRgamma and PPARgamma ligands in combination to inhibit proliferation and invasiveness in colon cancer cells. _h[electronic resource]
260			_bCancer letters _cNov 2010
300			_a65-74 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCell Movement _xdrug effects
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aColonic Neoplasms _xgenetics
650	0	4	_aCyclooxygenase 2 _xmetabolism
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Synergism
650	0	4	_aHCT116 Cells
650	0	4	_aHumans
650	0	4	_aLigands
650	0	4	_aMatrix Metalloproteinase 2 _xmetabolism
650	0	4	_aMatrix Metalloproteinase 9 _xmetabolism
650	0	4	_aNeoplasm Invasiveness
650	0	4	_aPPAR gamma _xagonists
650	0	4	_aPioglitazone
650	0	4	_aResponse Elements _xdrug effects
650	0	4	_aRetinoid X Receptor gamma _xagonists
650	0	4	_aThiazolidinediones _xpharmacology
650	0	4	_aTissue Inhibitor of Metalloproteinase-1 _xmetabolism
650	0	4	_aTissue Inhibitor of Metalloproteinase-2 _xmetabolism
650	0	4	_aTranscriptional Activation _xdrug effects
650	0	4	_aTretinoin _xanalogs & derivatives
700	1		_aRocchi, Paola
700	1		_aFerreri, Anna Maria
700	1		_aOrlandi, Marina
773	0		_tCancer letters _gvol. 297 _gno. 1 _gp. 65-74
856	4	0	_uhttps://doi.org/10.1016/j.canlet.2010.04.026 _zAvailable from publisher's website
999			_c19862714 _d19862714